Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression in Patients with Metastatic Non-Small-Cell Lung Cancer - A Randomized Phase 3 Trial

Disease Sites:

Lung

Staging:

Phase III

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Osmundson, Evan

Scope:

International

Participating Institutions:

Vanderbilt University

Open Date:

09-17-2025

Trial Type:

Treatment

Protocol ID:

NRGTHOCCTGBR38

National Clinical Trial ID:

NCT06686771

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available